Practical demonstration
AquilaScan operation
Follow the cassette preparation and the complete analysis workflow on the device.
AquilaScan drug screening device · pre-launch
Turn oral-fluid screening into a clear, documented workflow
AquilaScan combines digital cassette reading, test identification, history and record printing in one portable device—helping organize on-site screening and guide the next step in the protocol.
Qualitative screening. Configuration, availability and use depend on the relevant technical and regulatory validations.
During the conversation, we assess your scenario, panel, documentation and product availability for your application.
- Configuration
- Up to 9 variants per test
- Display
- 4.3-inch touchscreen
- Storage
- 100,000 records
- Connectivity
- Wi-Fi and optional 4G
Technical data provided by the manufacturer and subject to the commercial configuration.
Who it is for
When your operation needs to go beyond visual reading
AquilaScan may be considered when each test needs to be linked to a participant, a searchable history must be retained and a record needs to be generated on site.
- 01
On-site screening
A portable device and oral-fluid collection for running the workflow where the operation takes place.
- 02
Results with context
Identification, QR code and image help bring together the information required for each record.
- 03
Searchable history
Tests are stored on the device for later review.
- 04
Configurable panel
Cassette variants can be selected according to the application and available documentation.
Operating flow
Device, cassette and result in one process
Oral-fluid collection is non-invasive. The cassette is read by the device, and each test can be linked to the participant, stored and reviewed later.
- 01Oral-fluid sample cassette
- 02Guided digital reading
- 03On-site printed receipt
Test record
Less scattered information. More context for each test.
The reading is displayed on the device and can bring identification, an image, history and a printed record together in the same operational workflow.
Linked identification
The QR code reader helps link the test to the participant designated by the operation.
Visual record
The 2 MP camera adds an image to the record when required by the protocol.
On-site printout
The integrated printer produces the record without requiring another device.
Configurable connectivity
Mini USB, Wi-Fi and optional 4G provide channels for the operation's data workflow.
See the workflow before evaluating
From oral-fluid collection to the result record
Watch the cassette being prepared and placed in AquilaScan, followed by the reading and recordkeeping steps shown on the device.
Overview
How the oral-fluid test works
A visual overview of the oral-fluid sample collection and reading process using AquilaScan.
Want to assess the full workflow for your operation?
The demonstration presents the general workflow and does not replace training, instructions for use or the applicable protocol.
Multi-drug panel
Configuration tailored to the application
AquilaScan supports cassettes with up to nine drug variants. The combination of substances and detection thresholds depends on the configuration selected.
The codes shown represent categories published for the product. Confirm the exact panel in the technical documentation before defining the testing protocol.
- AMP
- Amphetamines
- BZO
- Benzodiazepines
- COC
- Cocaine
- KET
- Ketamine
- THC
- THC / cannabis
- MET
- Methamphetamine
- OPI
- Opiates
- MDMA
- Ecstasy (MDMA)
Technical data
AquilaScan specifications
Features may vary according to the commercial configuration, device version and validations applicable to the Brazilian market.
- Model
- WDTP-10
- Manufacturer
- C4 Development Ltd.
- Analysis type
- Qualitative oral-fluid screening
- Display
- 4.3-inch color touchscreen — 800 × 480
- Operating system
- Android
- RAM
- 1 GB DDR3
- Storage
- 100,000 test records
- Camera
- 2 megapixels
- Printer
- Integrated
- Identification
- QR code reader
- GPS
- Compatible
- Connectivity
- Mini USB, Wi-Fi and optional 4G
- Dimensions
- 20.9 × 9 × 5.74 cm
- Weight
- 452 g, including the battery
- Battery
- 7.4 V / 2,000 mAh lithium
- Reported battery life
- Up to 440 tests with printing or 600 without printing
- Operating temperature
- −5 °C to 50 °C
Regulatory context
Drug screening devices are now on Brazil's traffic enforcement agenda
CONTRAN Resolution No. 1,031/2026 provides for equipment capable of qualitatively detecting the presence of other psychoactive substances, provided that the applicable technical and certification requirements are met.
Read CONTRAN Resolution No. 1,031/2026- Qualitative reading
- The device indicates whether the target analyte was detected or not detected above the configured threshold; it does not measure the substance concentration.
- Specific certification
- The regulation does not automatically authorize any product. The model and its certificate must be verified for the intended application.
- Purpose and protocol
- Interpretation and occupational, clinical or legal effects depend on the purpose, protocol and applicable rules.
Before choosing
What needs to be validated for your application
A technical evaluation helps align intended use, configuration, procedure and documentation before a commercial decision is made.
- Which panel is required?
- Substances and thresholds depend on the cassette selected and must be specified in the technical documentation for the configuration.
- Is the result conclusive?
- The reading is qualitative and does not indicate concentration, time of use or psychomotor impairment. Laboratory confirmation must be used when required by the protocol.
- Is the model suitable for official use?
- Use depends on documentary proof of the certification applicable to the model and configuration. AquilaScan is in the pre-launch stage in Brazil.
- Is training required?
- Yes. The procedure must cover collection, reading, interpretation, recordkeeping and referral of cases that require confirmation.
- How will records be protected?
- Identification data, photographs and results require a defined purpose, access control, retention and security measures appropriate to the operation and the LGPD. View the Privacy Policy
Frequently asked questions
What to know before evaluating AquilaScan
Does AquilaScan provide a quantitative result?
No. The reading is qualitative: it indicates whether the target analyte was detected or not detected above the cassette threshold, without measuring the substance concentration.
Does a positive result confirm intoxication or recent use?
No. A qualitative reading does not indicate concentration, time of use, intoxication or degree of psychomotor impairment. When the protocol requires confirmation, the screening result must be referred for an appropriate laboratory method with a suitable chain of custody.
Which substances can be screened for?
The device supports cassettes with up to nine drug variants. The exact panel and its thresholds depend on the cassette selected and must be confirmed in the technical documentation for that configuration.
Is AquilaScan already approved for official enforcement use in Brazil?
The product is in the pre-launch stage in Brazil, and this page does not present an SBAC certificate for the model. Official use requires documentary proof of the certification provided for in CONTRAN Resolution No. 1,031/2026.
What safeguards are required for the records?
Identification data, photographs and results must have a defined purpose, controlled access, appropriate retention and processing consistent with the LGPD and the operation's rules.
Is training required to operate the device?
Yes. The protocol must cover collection, operation, interpretation and recordkeeping and, where applicable, laboratory confirmation and chain of custody.
Next step
Evaluate AquilaScan for your operation's protocol
Talk to Health Safety to review intended use, panel, technical documentation, training, availability and regulatory status before making a decision.
After you submit the form, the conversation opens in WhatsApp. Product in the pre-launch stage in Brazil.
- 01
Tell us about your scenario
Intended use, environment and planned workflow.
- 02
Review the configuration
Panel, thresholds and resources required for the protocol.
- 03
Get the next steps
Documentation, training and availability to be confirmed.